Researchers and doctors at GOSH have long been at the forefront of developing new treatments for Spinal Muscular Atrophy (SMA) and new research this year is helping us understand how Zolgensma, a gene therapy, can help.
A London team of surgeons, led by Surgeon Scientist Aswin Chari at GOSH, have explored whether the phrases “It’s not rocket science” or “It’s not brain surgery” are justified, in a study in the Christmas issue of The British Medical Journal.
Researchers at GOSH and UCL are the first to identify 'pre-resistance' signs in bacteria, indicators that particular bacteria are likely to become resistant to antibiotics in the future. This will allow doctors in the future to select the best treatments
Special molecules called fluorophores could ‘light up’ living cancer cells in future treatment of neuroblastoma, with new research by our GOSH doctors underway.
A team from Great Ormond Street Hospital (GOSH) and the UCL GOS Institute of Child Health (ICH) have shown how ‘blood spot’ testing new-borns could identify children who will go on to develop Spinal Muscular Atrophy, (SMA).
New research suggests our changing environment, as well as changing gene-environment interactions, could explain increasing rates of short-sightedness over time in the UK.
Teams based at UCL GOS ICH, including consultants from GOSH, have agreed the first research definition of what is meant by ‘Long COVID’ (post-acute COVID-19) in children and young people.
This exciting virtual event provided an opportunity for our community of researchers, funders, collaborators and external stakeholders to come together to celebrate the NIHR GOSH BRC's research activities and successes from across the last three years.
The National Institute for Health Research (NIHR) has announced that the Great Ormond Street Hospital (GOSH) Clinical Research Facility (CRF) is one of 28 centres from across the country to receive 5-years of funding to deliver early stage clinical resear
The world’s largest study of the genetics of critical Covid-19 involving more than 57,000 people, and many of our patients at GOSH, has revealed fresh details about some of the biological mechanisms behind the severe form of the disease.
For the first time, patients at Great Ormond Street Hospital and Southampton Children’s Hospital who are aged 12-17 years and immunocompromised are taking part in research to work out how they respond to COVID-19 vaccination.
New research has begun to unravel the mystery of why a particular form of leukaemia in infants has defied efforts to improve outcomes, despite significant improvements in treating older children.
A group of researchers investigate touch-free computer technologies with the Data Research, Innovation and Virtual Environments (DRIVE) unit at Great Ormond Street Hospital for Children (GOSH).
GOSH researchers, working with international collaborators, have shown that a new gene therapy has long term benefits for children with the severe immune disorder, Wiskott-Aldrich syndrome.
A commonly used means of delivering additional oxygen to children in intensive care is not as effective as many clinicians assume, new research involving GOSH teams has found.
Researchers at GOSH and University College London Great Ormond Street Institute of Child Health (UCL GOS ICH) are one of ten national teams to receive funding from a coalition of immune-related medical research charities.
Artificial intelligence in healthcare is a rapidly growing field. Children and teenagers often have insightful questions about AI, but are rarely involved in the development of new technologies. See how we're changing this...
Months of work will be completed in a few days as members of the public help to examine high-resolution images of the potentially blinding eye condition, uveitis, as part of a project working across GOSH, UCL GOS ICH and Moorfields Eye Hospital.
Dr Susan Shelmerdine, Consultant Paediatric Radiologist at Great Ormond Street Hospital (GOSH) discusses her research into using artificial intelligence (AI) to identify fractures in children.